Data / New clinical trials / Crohn Disease
New Crohn Disease clinical trials: 277 posted since Nov 2024
The full list. New Crohn Disease clinical trials: 277 rows for $13.85, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 14 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/crohn-disease, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
277 clinical studies in Crohn Disease were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 61 have an industry sponsor and 220 are recruiting or about to. The newest, NCT07925450, was posted on November 9, 2026: Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease (Weill Medical College of Cornell University).
The request: Every new Crohn Disease clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 277New trials
- 61Industry sponsored
- 220Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 277, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07925450 | Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease | Weill Medical College of Cornell University | Phase 4 | Recruiting | Crohn's Disease, Iron Deficiency Anemia | 150 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923383 | An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates | Sanofi | Phase 1 | Not yet recruiting | Ulcerative Colitis, Crohn's Disease | 25 | clinicaltrials.gov | |
| November 4, 2026 | NCT07916727 | Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study | Austin Health | Not applicable | Recruiting | Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), Pregnancy | 50 | Australia | clinicaltrials.gov |
| October 28, 2026 | NCT07900945 | Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants | Keymed Biosciences Co.Ltd | Phase 1 | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | 48 | China | clinicaltrials.gov |
| October 27, 2026 | NCT07897539 | Mechanical Bowel Preparation Prior To Sphincter-Sparing Surgery For Complex Anal Fistulae | Region Skane | Not applicable | Not yet recruiting | Anal Fistula, Rectal Fistula, Crohn Disease | 116 | Sweden | clinicaltrials.gov |
| October 23, 2026 | NCT07892651 | MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | Axiom Bioregistry | Observational | Not yet recruiting | Antiphospholipid (aPL)-Positive, Rheumatic Arthritis, Celiac Disease, Focal Segmental Glomerulosclerosis (FSGS)... | 5,000 | Jordan | clinicaltrials.gov |
| October 22, 2026 | NCT07888023 | Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative (UC), Malnutrition | 210 | clinicaltrials.gov | |
| October 20, 2026 | NCT07884045 | Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's Disease | University Hospital, Motol | Not applicable | Recruiting | Crohn Disease (CD) | 124 | Czechia | clinicaltrials.gov |
| October 20, 2026 | NCT07883044 | Microencapsulated Sodium Propionate in IBD Microbiota Modulation | University of Padova | Not applicable | Recruiting | Crohn Disease | 50 | Italy | clinicaltrials.gov |
| October 16, 2026 | NCT07877649 | Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease | First Affiliated Hospital, Sun Yat-Sen University | Observational | Not yet recruiting | Inflammatory Bowel Diseases (IBD), Crohn Disease, Colitis, Ulcerative | 2,000 | clinicaltrials.gov | |
| October 13, 2026 | NCT07872449 | Risankizumab for Refractory Perianal Fistulizing Crohn's Disease | Yuki Horio | Phase 4 | Recruiting | Crohn Disease, Perianal Fistula, Perianal Fistula Due to Crohn's Disease, Perianal Crohn's Disease | 25 | Japan | clinicaltrials.gov |
| October 13, 2026 | NCT07871669 | Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH). | Wuhan Kangfude Urolithiasis Research Institute Co., Ltd. | Phase 2 | Not yet recruiting | Enteric Hyperoxaluria | 30 | clinicaltrials.gov | |
| October 13, 2026 | NCT07871383 | Effect of Intestinal Carriage of *Pilosibacter Rotomagensis* on Intestinal Inflammatory Activity | University Hospital, Rouen | Observational | Not yet recruiting | Crohn's Diseases | 116 | France | clinicaltrials.gov |
| October 2, 2026 | NCT07855055 | Early Changes in Inflammatory Indices and Healing in IBD | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Disease, Ulcerative Colitis, Crohn Disease | 138 | clinicaltrials.gov | |
| October 1, 2026 | NCT07851207 | A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian Setting | Janssen-Cilag Ltd. | Observational | Not yet recruiting | Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases | 200 | clinicaltrials.gov | |
| September 30, 2026 | NCT07848737 | A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis | Janssen-Cilag, S.A. | Observational | Not yet recruiting | Colitis, Ulcerative, Crohn Disease | 200 | Spain | clinicaltrials.gov |
| September 22, 2026 | NCT07833332 | Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Not applicable | Recruiting | Crohn Disease (CD), Intestinal Stricture, Intestinal Fibrosis | 244 | China | clinicaltrials.gov |
| September 22, 2026 | NCT07832435 | A Phase 2, Placebo-Controlled Study of Oral RXC008 for Crohn's Strictures | Redx Pharma Ltd | Phase 2 | Not yet recruiting | Strictures Due to Crohn's Disease | 180 | clinicaltrials.gov | |
| September 17, 2026 | NCT07824791 | Prediction of Postoperative Recurrence in Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn Disease (CD), Postoperative Recurrence and Metastasis | 250 | China | clinicaltrials.gov |
| September 17, 2026 | NCT07824726 | Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory... | PhoenixLAB srls | Not applicable | Not yet recruiting | Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease), Crohn Disease (CD) | 30 | Italy | clinicaltrials.gov |
| September 16, 2026 | NCT07822087 | A Phase 1 Study of ATORM-C in Patients With Crohn's Disease | ORGANOIDSCIENCES LTD. | Phase 1 | Recruiting | Crohn's Diseases, Crohn's Disease | 18 | South Korea | clinicaltrials.gov |
| September 16, 2026 | NCT07821645 | Modulen IBD for Induction and Maintenance of Remission in Pediatric Crohn's Disease | Assiut University | Observational | Not yet recruiting | Crohn Disease, Inflammatory Bowel Diseases, Pediatric Crohns Disease | 40 | clinicaltrials.gov | |
| September 14, 2026 | NCT07818473 | Conventional vs Biologic Therapy in Pediatric IBD | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 100 | clinicaltrials.gov | |
| September 10, 2026 | NCT07814274 | Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development | University of British Columbia | Observational | Not yet recruiting | Inflammatory Bowel Disease (IBD) | 95 | Canada | clinicaltrials.gov |
| September 10, 2026 | NCT07812675 | Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion... | Centre Hospitalier Universitaire de Nīmes | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn's Disease, Skin Diseases, Dermatitis | 82 | France | clinicaltrials.gov |
| September 4, 2026 | NCT07804511 | Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission | University Hospital, Grenoble | Not applicable | Not yet recruiting | Inflammatory Bowel Diseases (IBD), Fatigue, Crohn Disease (CD), Ulcerative Colitis (UC) | 120 | France | clinicaltrials.gov |
| September 2, 2026 | NCT07799506 | Accurately Profiling the Changes and Functions of Key Microflora in the Whole Intestinal Microenvironment Based on the Visual Sampling... | Changhai Hospital | Observational | Not yet recruiting | Crohn's Disease (CD), Ulcerative Colitis (UC) | 250 | clinicaltrials.gov | |
| September 2, 2026 | NCT07799428 | Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease | Anabio R&D | Not applicable | Recruiting | Crohn Disease and Ulcerative Colitis | 150 | Vietnam | clinicaltrials.gov |
| September 1, 2026 | NCT07796568 | Virtual Group Therapy for IBD Patients With Anxiety and Depression | University of Chicago | Not applicable | Not yet recruiting | Crohn's Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD), Anxiety, Depression | 16 | United States | clinicaltrials.gov |
| August 31, 2026 | NCT07795476 | Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient... | PharmaNest, Inc | Observational | Not yet recruiting | Crohn Disease, Fibrostenotic Crohn's Disease, CD - Crohn's Disease | 100 | Spain | clinicaltrials.gov |
| August 31, 2026 | NCT07794410 | A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect... | Asian Institute of Gastroenterology, India | Not applicable | Recruiting | Crohn Disease (CD), Cryptoglandular Perianal Fistula | 50 | India | clinicaltrials.gov |
| August 28, 2026 | NCT07791888 | R-3750 in Patients With Crohn's Disease | Rise Therapeutics LLC | Phase 1 | Not yet recruiting | Crohn Disease (CD) | 40 | clinicaltrials.gov | |
| August 28, 2026 | NCT07791862 | Familial Inflammatory Bowel Disease Early Risk | Seattle Children's Hospital | Observational | Recruiting | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn Disease (CD), Ulcerative Colitis (UC) | 7,000 | United States | clinicaltrials.gov |
| August 26, 2026 | NCT07788131 | Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis (UC) | 120 | clinicaltrials.gov | |
| August 25, 2026 | NCT07784114 | Incremental Value of Traditional Chinese Medicine Features in Two-Stage Pre-Endoscopic Prediction | Beijing University of Chinese Medicine | Observational | Completed | Ulcerative Colitis (Disorder), Crohn Disease (CD), Inflammatory Bowel Diseases, Colorectal Neoplasms | 1,500 | clinicaltrials.gov | |
| August 24, 2026 | NCT07782021 | MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease | Icahn School of Medicine at Mount Sinai | Phase 4 | Not yet recruiting | Crohn's Disease, Perianal Fistula | 50 | United States | clinicaltrials.gov |
| August 24, 2026 | NCT07781215 | E-nose in Evaluating Colitis Activity | Tampere University Hospital | Observational | Not yet recruiting | IBD (Inflammatory Bowel Disease) | 120 | clinicaltrials.gov | |
| August 20, 2026 | NCT07775352 | Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease | Mahidol University | Not applicable | Recruiting | Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative | 137 | Thailand | clinicaltrials.gov |
| August 18, 2026 | NCT07770425 | Lesion Size Measurement During Gastrointestinal Endoscopies | Centre hospitalier de l'Université de Montréal (CHUM) | Observational | Recruiting | Polyp of Colon, Crohn Disease | 3,000 | Canada | clinicaltrials.gov |
| August 18, 2026 | NCT07769437 | Non-nutritive Sweeteners in Inflammatory Bowel Disease | University Hospitals Cleveland Medical Center | Not applicable | Recruiting | Inflamatory Bowel Disease, Crohn Disease (CD) | 40 | United States | clinicaltrials.gov |
| August 14, 2026 | NCT07766733 | The Safety and Efficacy of Good Feeling Power® for IBD Patients | Good Feeling Products GmbH | Not applicable | Completed | Ulcerative Colitis (UC), Crohn Disease (CD) | 36 | Spain | clinicaltrials.gov |
| August 11, 2026 | NCT07757217 | Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease | Shanghai 10th People's Hospital | Observational | Completed | Crohn's Disease | 437 | China | clinicaltrials.gov |
| August 10, 2026 | NCT07753850 | A Study of SL-325 in Crohn's Disease Patients | Shattuck Labs, Inc. | Phase 2 | Recruiting | Crohn's Disease | 232 | United States | clinicaltrials.gov |
| August 5, 2026 | NCT07748338 | Ustekinumab Real World Evidence Study | University Hospital Southampton NHS Foundation Trust | Observational | Completed | Crohn's Disease | 601 | United Kingdom | clinicaltrials.gov |
| August 5, 2026 | NCT07746765 | A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting | Janssen Sciences Ireland UC | Observational | Not yet recruiting | Crohn Disease, Colitis, Ulcerative | 35 | clinicaltrials.gov | |
| July 31, 2026 | NCT07740499 | TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease | IRCCS San Raffaele | Observational | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) | 80 | Italy | clinicaltrials.gov |
| July 24, 2026 | NCT07724990 | A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis | Catholic University of the Sacred Heart | Not applicable | Recruiting | Ulcerative Colitis, Crohn Disease | 20 | Italy | clinicaltrials.gov |
| July 22, 2026 | NCT07719426 | Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a... | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Observational | Recruiting | Crohn Disease (CD), Colitis Ulcerative | 800 | France | clinicaltrials.gov |
| July 17, 2026 | NCT07710287 | Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD | IRCCS Policlinico S. Donato | Observational | Recruiting | Ulcerative Colitis (UC), Crohn Disease | 100 | Italy | clinicaltrials.gov |
| July 13, 2026 | NCT07697547 | Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease | Shanghai 10th People's Hospital | Observational | Completed | Inflammatory Bowel Disease (IBD), Crohn's Disease | 84 | China | clinicaltrials.gov |
| July 13, 2026 | NCT07697456 | Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis | AbbVie | Phase 2 | Recruiting | Crohn's Disease, Ulcerative Colitis | 2,000 | Canada, Israel, Japan, Taiwan, United States | clinicaltrials.gov |
| July 10, 2026 | NCT07694674 | Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease | Shanghai 10th People's Hospital | Observational | Recruiting | Inflamatory Bowel Disease, Crohn Disease (CD) | 198 | China | clinicaltrials.gov |
| July 10, 2026 | NCT07694609 | Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable Diseases | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Active not recruiting | Inflammatory Bowel Diseases (IBD), Crohn Disease, Ulcerative Colitis (UC) | 200 | Italy | clinicaltrials.gov |
| July 9, 2026 | NCT07694362 | Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel Disease | Vall d'Hebron Institute Research | Not applicable | Completed | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Ulcerative Colitis (UC), Crohn's Disease... | 60 | Spain | clinicaltrials.gov |
| July 8, 2026 | NCT07691138 | Stopping PPI Therapy in Inactive IBD | University of Nottingham | Phase 4 | Recruiting | Ulcerative Colitis (UC), Crohn's Disease | 80 | United Kingdom | clinicaltrials.gov |
| July 7, 2026 | NCT07686757 | INSIGHT-IBD Pragmatic Study | Specialty Networks Research. | Phase 4 | Enrolling by invitation | Ulcerative Colitis (UC), Crohn Disease (CD) | 400 | United States | clinicaltrials.gov |
| July 7, 2026 | NCT07686406 | IBD Biomarker Discovery and Validation Platform | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD) | 6,000 | China | clinicaltrials.gov |
| July 2, 2026 | NCT07682038 | Retrospective Observational Multicenter Study on the Treatment Patterns, Extra-Intestinal Manifestations, Resource Utilisation, and... | LOGEX | Observational | Not yet recruiting | Crohn Disease, Inflammatory Bowel Disease (IBD), Colitis Ulcerative | 3,500 | clinicaltrials.gov | |
| July 2, 2026 | NCT07680283 | Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD | The Cleveland Clinic | Not applicable | Recruiting | Crohn's Disease (CD) | 22 | United States | clinicaltrials.gov |
| June 30, 2026 | NCT07677514 | A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease | Jiangsu Carephar Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Crohn's Disease | 156 | China, United States | clinicaltrials.gov |
| June 29, 2026 | NCT07673497 | Can Vitamin D Replacement Correct Chronic Disease Anemia? | Gazi University | Phase 4 | Completed | Vitamin D, Iron Deficiency and Overload, Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) | 43 | Turkey (Türkiye) | clinicaltrials.gov |
| June 26, 2026 | NCT07671872 | Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease | University of Miami | Not applicable | Recruiting | Crohn's Disease, Active, Crohn's Disease (CD), Diet Interventions | 122 | United States | clinicaltrials.gov |
| June 26, 2026 | NCT07671313 | Online Pain Education for Crohn's Disease and Ulcerative Colitis | Cedars-Sinai Medical Center | Not applicable | Not yet recruiting | Crohn's Disease, Ulcerative Colitis (UC), Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) | 60 | United States | clinicaltrials.gov |
| June 23, 2026 | NCT07663526 | Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 4 | Recruiting | Crohn's Disease | 50 | China | clinicaltrials.gov |
| June 23, 2026 | NCT07663201 | Cardiovascular Risk in Patients With IBD | IRCCS Policlinico S. Donato | Observational | Not yet recruiting | Ulcerative Colitis (UC), Crohn's Diseases, Cardiovascular Risk | 300 | clinicaltrials.gov | |
| June 18, 2026 | NCT07656233 | Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life... | Universitas Indonesia | Not applicable | Completed | Ulcerative Colitis (UC), Crohn Disease (CD) | 50 | Indonesia | clinicaltrials.gov |
| June 17, 2026 | NCT07654751 | A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically | Janssen Research & Development, LLC | Phase 4 | Recruiting | Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic | 10 | United States | clinicaltrials.gov |
| June 17, 2026 | NCT07652840 | Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Anti-TNF Therapy | Izmir Katip Celebi University | Not applicable | Completed | Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), Adherence, Patient, Structured Education | 140 | Turkey (Türkiye) | clinicaltrials.gov |
| June 17, 2026 | NCT07652632 | Regenerative Endoscopy in Refractory Perianal Crohn's Disease | Asian Institute of Gastroenterology, India | Not applicable | Recruiting | Crohn Disease (CD), Perianal Crohns Disease | 50 | India | clinicaltrials.gov |
| June 16, 2026 | NCT07649720 | NaviCam Patency Capsule to Verify Gastrointestinal Patency | AnX Robotica Corp. | Not applicable | Not yet recruiting | Intestinal Stricture, Crohn Disease, NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy, Abdominal Pain | 25 | United States | clinicaltrials.gov |
| June 16, 2026 | NCT07649408 | Impact of Advanced Crohn's Disease Therapies on Sleep Quality | Shmuel Kivity, MD | Observational | Recruiting | Crohn Disease (CD) | 30 | Israel | clinicaltrials.gov |
| June 15, 2026 | NCT07647640 | Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study | Maastricht University Medical Center | Observational | Recruiting | Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD) | 600 | Netherlands | clinicaltrials.gov |
| June 12, 2026 | NCT07644390 | Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests... | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Completed | Crohn Disease (CD), Dynamic Prediction Model | 500 | clinicaltrials.gov | |
| June 12, 2026 | NCT07644117 | Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease | Shmuel Kivity, MD | Observational | Recruiting | IBD (Inflammatory Bowel Disease), Crohn Disease (CD), Ulcerative Colitis (UC) | 40 | Israel | clinicaltrials.gov |
| June 9, 2026 | NCT07636304 | VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission | University of Gdansk | Early phase 1 | Enrolling by invitation | Inflammatory Bowel Diseases (IBD), Remission of IBD, In Adults, Inflammatory Bowel Disease (Crohn's Disease; Ulcerative... | 15 | Poland | clinicaltrials.gov |
| June 8, 2026 | NCT07632573 | A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult | Benethera (Shaoxing) Biotechnology Co., Ltd. | Phase 1 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis (Disorder), Ulcerative Colitis Acute, IBD (Inflammatory Bowel Disease), CD... | 68 | China | clinicaltrials.gov |
| June 5, 2026 | NCT07630883 | A Pilot Study: Micro and NanoPlastics in Association With Crohn's Disease | Mak Wing Yan | Observational | Not yet recruiting | Crohn's Disease (CD) | 90 | Hong Kong | clinicaltrials.gov |
| June 5, 2026 | NCT07629245 | Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of... | Assistance Publique Hopitaux De Marseille | Phase 1/2 | Recruiting | Crohn Disease (CD) | 25 | France | clinicaltrials.gov |
| June 4, 2026 | NCT07625293 | DB-3Q for the Treatment of Medically Refractory Crohn's Disease | Direct Biologics, LLC | Phase 2 | Recruiting | Crohn Disease (CD) | 36 | United States | clinicaltrials.gov |
| June 2, 2026 | NCT07621783 | Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context | Imelda GI Clinical Research Center | Observational | Recruiting | Crohn Disease (CD), Ulcerative Colitis (UC) | 100 | Belgium | clinicaltrials.gov |
| June 2, 2026 | NCT07619547 | Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Observational | Recruiting | Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis | 100 | United States | clinicaltrials.gov |
| June 1, 2026 | NCT07616687 | Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Phase 4 | Recruiting | Crohn Disease (CD), Intensification | 210 | France | clinicaltrials.gov |
| May 28, 2026 | NCT07610694 | Eating Disorders in Patients With IBD | Federico II University | Observational | Completed | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn Disease (CD), Ulcerative Colitis (UC)... | 355 | Italy | clinicaltrials.gov |
| May 26, 2026 | NCT07606339 | A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis | Janssen-Cilag Pharma GmbH | Observational | Recruiting | Crohn Disease, Colitis, Ulcerative | 35 | Austria | clinicaltrials.gov |
| May 20, 2026 | NCT07600255 | Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's Disease | Second Affiliated Hospital of Wenzhou Medical University | Observational | Completed | Crohn's Diseases | 156 | China | clinicaltrials.gov |
| May 19, 2026 | NCT07597577 | Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Completed | Crohn Disease, Upadacitinib | 3 | China | clinicaltrials.gov |
| May 18, 2026 | NCT07593352 | Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD) | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | Observational | Recruiting | IBD and Renal Involement, Chronic Kidney Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 6,000 | Poland | clinicaltrials.gov |
| May 15, 2026 | NCT07590518 | VR Therapies for IBD | Brennan Spiegel | Not applicable | Not yet recruiting | Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn Disease (CD), Anxiety | 76 | United States | clinicaltrials.gov |
| May 15, 2026 | NCT07590271 | Research on the Whole Process of AI Intelligent Management System for the Diagnosis and Treatment of Inflammatory Bowel Diseases | Taichung Veterans General Hospital | Observational | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Crohn's Disease (CD), Ulcerative Colitis (UC)... | 4,500 | Taiwan | clinicaltrials.gov |
| May 11, 2026 | NCT07577843 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 460 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France... | clinicaltrials.gov |
| May 4, 2026 | NCT07564609 | the REMONO-CD and the REMONO-UC Studies | University Hospital, Clermont-Ferrand | Observational | Enrolling by invitation | Crohn Disease (CD), Ulcerative Colitis (UC) | 420 | France | clinicaltrials.gov |
| April 29, 2026 | NCT07555808 | MRI-Based Screening in a Retrospective Cohort Reveals Adverse Prognosis of Asymptomatic Perianal Fistulas in Crohn's Disease: A Long-term... | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Completed | Crohn's Disease | 669 | clinicaltrials.gov | |
| April 23, 2026 | NCT07546955 | AI-Enhanced Wide-Field Endoscopic Fluorescence Mapping of Gastrointestinal Mucosal Permeability in IBD - A Pilot Study in IBD Patients and... | Hamilton Health Sciences Corporation | Observational | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), NON-IBD | 70 | clinicaltrials.gov | |
| April 22, 2026 | NCT07545317 | Real-World Study of IL-23 Inhibitors in Active Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn's Disease | 665 | China | clinicaltrials.gov |
| April 22, 2026 | NCT07544160 | BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) | iCell Gene Therapeutics | Phase 1/2 | Not yet recruiting | Inflammatory Bowel Diseases (IBD) | 18 | China | clinicaltrials.gov |
| April 21, 2026 | NCT07541261 | A Real-World Study of Guselkumab in Ulcerative Colitis and Crohn's Disease in Saudi Arabia | Janssen Research & Development, LLC | Observational | Recruiting | Colitis, Ulcerative, Crohn Disease | 100 | Saudi Arabia | clinicaltrials.gov |
| April 15, 2026 | NCT07532213 | A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab | Janssen-Cilag A.G., Switzerland | Observational | Recruiting | Inflammatory Bowel Disease, Colitis, Ulcerative, Crohn Disease | 50 | Switzerland | clinicaltrials.gov |
| April 15, 2026 | NCT07531342 | Repetitive Transcranial Magnetic Stimulation Combined With Anti-inflammatory Diet in Crohn's Disease | Cairo University | Not applicable | Recruiting | Crohn's Disease | 50 | Egypt | clinicaltrials.gov |
| April 14, 2026 | NCT07528040 | An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease... | Shanghai 10th People's Hospital | Observational | Not yet recruiting | Crohn's Disease (CD) | 88 | China | clinicaltrials.gov |
| April 13, 2026 | NCT07524244 | Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis | Fuller Research Foundation | Not applicable | Recruiting | Rheumatoid Arthritis (RA), Crohn's Disease (CD), Ulcerative Colitis (UC) | 160 | United States | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Sixth Affiliated Hospital, Sun Yat-sen University | 11 | September 22, 2026 |
| Second Affiliated Hospital of Wenzhou Medical University | 9 | May 20, 2026 |
| Assiut University | 6 | October 22, 2026 |
| Sanofi | 5 | November 6, 2026 |
| Janssen Research & Development, LLC | 5 | June 17, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 5 | March 2, 2026 |
| Asian Institute of Gastroenterology, India | 4 | August 31, 2026 |
| Shanghai 10th People's Hospital | 4 | August 11, 2026 |
| Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 4 | July 22, 2026 |
| University Hospital, Clermont-Ferrand | 4 | May 4, 2026 |
| Takeda | 4 | February 11, 2026 |
| University of British Columbia | 3 | September 10, 2026 |
| University Hospital, Grenoble | 3 | September 4, 2026 |
| IRCCS San Raffaele | 3 | July 31, 2026 |
| IRCCS Policlinico S. Donato | 3 | July 17, 2026 |
| AbbVie | 3 | July 13, 2026 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 | July 10, 2026 |
| Shmuel Kivity, MD | 3 | June 16, 2026 |
| Assistance Publique Hopitaux De Marseille | 3 | June 5, 2026 |
| Eli Lilly and Company | 3 | March 19, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Observational | 126 | October 23, 2026 |
| Not applicable | 81 | November 4, 2026 |
| Phase 4 | 21 | November 9, 2026 |
| Phase 2 | 21 | October 13, 2026 |
| Phase 1 | 9 | November 6, 2026 |
| Phase 3 | 7 | May 11, 2026 |
| Phase 1/2 | 6 | June 5, 2026 |
| Early phase 1 | 4 | June 9, 2026 |
| Phase 2/3 | 2 | September 29, 2025 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 56 | November 9, 2026 |
| China | 53 | October 28, 2026 |
| France | 35 | October 13, 2026 |
| Italy | 30 | October 20, 2026 |
| Canada | 24 | September 10, 2026 |
| United Kingdom | 17 | August 5, 2026 |
| Poland | 16 | June 9, 2026 |
| Germany | 16 | May 11, 2026 |
| Spain | 14 | September 30, 2026 |
| Belgium | 13 | June 2, 2026 |
| Netherlands | 12 | June 15, 2026 |
| Israel | 11 | July 13, 2026 |
| Czechia | 10 | October 20, 2026 |
| Turkey (Türkiye) | 9 | June 29, 2026 |
| Hungary | 9 | May 11, 2026 |
| Sweden | 8 | October 27, 2026 |
| Japan | 8 | October 13, 2026 |
| South Korea | 8 | September 16, 2026 |
| India | 8 | August 31, 2026 |
| Australia | 7 | November 4, 2026 |
| Taiwan | 7 | July 13, 2026 |
| Austria | 7 | May 26, 2026 |
| Brazil | 7 | May 11, 2026 |
| Denmark | 7 | March 30, 2026 |
| Slovakia | 6 | May 11, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.